119th Congress · introduced in the House · May 19, 2025
Gerald E. Connolly Esophageal Cancer Awareness Act of 2025
Official title from Congress.gov
Latest action (Jun 9, 2026): Became Public Law No: 119-96.
View on Congress.govPolicy area: Government Operations and Politics
Congressional Research Service summary, version: Introduced in House (May 19, 2025)
Esophageal Cancer Awareness Act
This bill requires the Government Accountability Office to report to Congress on (1) the impact of esophageal cancer-related health care spending under the Federal Employees Health Benefits Program (FEHBP) for federal employees and retirees diagnosed with esophageal cancer, and (2) how often FEHBP participants with a high risk of esophageal cancer undergo screenings according to established guidelines.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Became Public Law No: 119-96.
Became Public Law No: 119-96.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Message on Senate action sent to the House.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S2397-2398)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Senate Committee on Homeland Security and Governmental Affairs discharged by Unanimous Consent.
Senate Committee on Homeland Security and Governmental Affairs discharged by Unanimous Consent.
Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2390-2391)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2390-2391)
DEBATE - The House proceeded with forty minutes of debate on H.R. 3490.
Considered under suspension of the rules. (consideration: CR H2390-2392)
Mr. Comer moved to suspend the rules and pass the bill, as amended.
Ordered to be Reported by the Yeas and Nays: 42 - 0.
Committee Consideration and Mark-up Session Held
Referred to the House Committee on Oversight and Government Reform.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Cancer · Government employee pay, benefits, personnel management · Government information and archives · Health care costs and insurance
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
1 citation.
ESOPHAGEAL CANCER ACTION NETWORK (ECAN) · lobbying firm or registrant: MGD STRATEGIES LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Aug 7, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
Support passage of the Clinical Trials Modernization Act (S. 4440/H.R. 3521) Support passage of the Gerald E. Connolly Esophageal Cancer Awareness Act (HR3490; Public Law No. 119-96)
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing